189 related articles for article (PubMed ID: 36722586)
1. Use of methylene blue to treat vasoplegia syndrome in cystic fibrosis patients undergoing lung transplantation: A case series.
Washington GC; O'Donnell CT; Madhok J; Williams KM; Hill CC
Ann Card Anaesth; 2023; 26(1):36-41. PubMed ID: 36722586
[TBL] [Abstract][Full Text] [Related]
2. Methylene Blue for Vasoplegia When on Cardiopulmonary Bypass During Double-Lung Transplantation.
Carley M; Schaff J; Lai T; Poppers J
A A Case Rep; 2015 Oct; 5(8):127-30. PubMed ID: 26466303
[TBL] [Abstract][Full Text] [Related]
3. Methylene Blue for Vasoplegia During Extracorporeal Membrane Oxygenation Support.
Ortoleva J; Roberts RJ; Devine LT; French A; Kawabori M; Chen F; Shelton K; Dalia AA
J Cardiothorac Vasc Anesth; 2021 Sep; 35(9):2694-2699. PubMed ID: 33455885
[TBL] [Abstract][Full Text] [Related]
4. Methylene Blue for Vasoplegic Syndrome After Cardiac Operation: Early Administration Improves Survival.
Mehaffey JH; Johnston LE; Hawkins RB; Charles EJ; Yarboro L; Kern JA; Ailawadi G; Kron IL; Ghanta RK
Ann Thorac Surg; 2017 Jul; 104(1):36-41. PubMed ID: 28551045
[TBL] [Abstract][Full Text] [Related]
5. Methylene Blue Does Not Improve Vasoplegia After Left Ventricular Assist Device Implantation.
Saha A; Jennings DL; Ning Y; Kurlansky P; Miltiades AN; Spellman JL; Sanchez J; Yuzefpolskaya M; Colombo PC; Takayama H; Naka Y; Takeda K
Ann Thorac Surg; 2021 Mar; 111(3):800-808. PubMed ID: 32758558
[TBL] [Abstract][Full Text] [Related]
6. Methylene Blue for Vasoplegic Syndrome.
Booth AT; Melmer PD; Tribble B; Mehaffey JH; Tribble C
Heart Surg Forum; 2017 Oct; 20(5):E234-E238. PubMed ID: 29087290
[TBL] [Abstract][Full Text] [Related]
7. The additional use of methylene blue has a decatecholaminisation effect on cardiac vasoplegic syndrome after cardiac surgery.
Petermichl W; Gruber M; Schoeller I; Allouch K; Graf BM; Zausig YA
J Cardiothorac Surg; 2021 Jul; 16(1):205. PubMed ID: 34321019
[TBL] [Abstract][Full Text] [Related]
8. Methylene blue for postcardiopulmonary bypass vasoplegic syndrome: A cohort study.
Mazzeffi M; Hammer B; Chen E; Caridi-Scheible M; Ramsay J; Paciullo C
Ann Card Anaesth; 2017; 20(2):178-181. PubMed ID: 28393777
[TBL] [Abstract][Full Text] [Related]
9. Methylene Blue as an Adjunct to Treat Vasoplegia in Patients Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass: A Literature Review.
Arevalo VN; Bullerwell ML
AANA J; 2018 Dec; 86(6):455-463. PubMed ID: 31584419
[TBL] [Abstract][Full Text] [Related]
10. Incidence of Intraoperative Vasoplegic Syndrome in Lung Transplantation.
Lam S; Mofidi S; Saddic L; Neelankavil J; Wingert T; Cheng D; Grogan T; Methangkool E
J Cardiothorac Vasc Anesth; 2023 Dec; 37(12):2531-2537. PubMed ID: 37775341
[TBL] [Abstract][Full Text] [Related]
11. Vasoplegic Syndrome in Patients Undergoing Cardiac Surgery: A Literature Review.
Nash CM
AACN Adv Crit Care; 2021 Jun; 32(2):137-145. PubMed ID: 34161970
[TBL] [Abstract][Full Text] [Related]
12. Methylene blue is associated with poor outcomes in vasoplegic shock.
Weiner MM; Lin HM; Danforth D; Rao S; Hosseinian L; Fischer GW
J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1233-8. PubMed ID: 23972738
[TBL] [Abstract][Full Text] [Related]
13. Vasoplegic syndrome after cardiovascular surgery: A review of pathophysiology and outcome-oriented therapeutic management.
Datt V; Wadhhwa R; Sharma V; Virmani S; Minhas HS; Malik S
J Card Surg; 2021 Oct; 36(10):3749-3760. PubMed ID: 34251716
[TBL] [Abstract][Full Text] [Related]
14. Methylene Blue: Magic Bullet for Vasoplegia?
Hosseinian L; Weiner M; Levin MA; Fischer GW
Anesth Analg; 2016 Jan; 122(1):194-201. PubMed ID: 26678471
[TBL] [Abstract][Full Text] [Related]
15. Intraoperative vasoplegia: methylene blue to the rescue!
McCartney SL; Duce L; Ghadimi K
Curr Opin Anaesthesiol; 2018 Feb; 31(1):43-49. PubMed ID: 29176374
[TBL] [Abstract][Full Text] [Related]
16. Use of Intravenous Hydroxocobalamin without Methylene Blue for Refractory Vasoplegic Syndrome After Cardiopulmonary Bypass.
Peyko V; Finamore M
Am J Case Rep; 2021 Jun; 22():e930890. PubMed ID: 34143764
[TBL] [Abstract][Full Text] [Related]
17. Guanylate cyclase inhibition by methylene blue as an option in the treatment of vasoplegia after a severe burn. A medical hypothesis.
Farina Junior JA; Celotto AC; da Silva MF; Evora PR
Med Sci Monit; 2012 May; 18(5):HY13-7. PubMed ID: 22534716
[TBL] [Abstract][Full Text] [Related]
18. Hydroxocobalamin Versus Methylene Blue for Vasoplegic Syndrome in Cardiothoracic Surgery: A Retrospective Cohort.
Furnish C; Mueller SW; Kiser TH; Dufficy L; Sullivan B; Beyer JT
J Cardiothorac Vasc Anesth; 2020 Jul; 34(7):1763-1770. PubMed ID: 32115360
[TBL] [Abstract][Full Text] [Related]
19. The Story of Nitric Oxide, Sepsis and Methylene Blue: A Comprehensive Pathophysiologic Review.
Saha BK; Burns SL
Am J Med Sci; 2020 Oct; 360(4):329-337. PubMed ID: 32631574
[TBL] [Abstract][Full Text] [Related]
20. Methylene blue for vasoplegic syndrome in cardiopulmonary bypass surgery: A systematic review and meta-analysis.
Perdhana F; Kloping NA; Witarto AP; Nugraha D; Yogiswara N; Luke K; Kloping YP; Rehatta NM
Asian Cardiovasc Thorac Ann; 2021 Oct; 29(8):717-728. PubMed ID: 33653154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
